Author: Vikas Kumar
21 November 2022
Brain mapping can be conceived as a higher form of neuroimaging, producing brain images supplemented by the result of additional (imaging or non-imaging) data processing or analysis, such as measures of behavior in brain regions. The increasing integration of advanced technology in the healthcare facilities for better treatment owing to an increasing market size of brain imaging instruments. Furthermore, the rising prevalence of brain disorders coupled with the increasing efforts to understand the brain complexities for future disease treatment catalyzing the market growth of brain mapping instruments. For instance, as per the CDC, every year, more than 795,000 people in the United States have a stroke. About 610,000 of these are first or new strokes.
The Brain Mapping Instrument Market is expected to grow at a steady rate of around 13% owing to the rising cases of cancer diseases.Major companies in the market offer Medtronic, GENERAL ELECTRIC COMPANY, Koninklijke Philips N.V., and Siemens Healthcare Private Limited
For a detailed analysis of the Global Brain Mapping Instrument Market browse through – https://univdatos.com/report/brain-mapping-instruments-market/
Based on the product type, the market has been categorized into functional magnetic resonance imaging (fMRI), computed axial tomography (CAT), electroencephalography (EGG), magnetoencephalography, functional near-infrared spectroscopy (fNIRS), positron emission tomography (PET), and others. Among them, the electroencephalography segment is expected to have significant growth in the market. The EEG measures the electrical activity of the brain, and it is helpful in the diagnosis of many diseases including seizures, sleep disorders, strokes, and others. The rising prevalence of sleeping disorders coupled with the increasing number of stroke incidents are attributed to the rising market the brain mapping instruments.
Based on the end-users, the market has been categorized into hospitals, diagnostic centers, and others. Among them, the diagnostic center’s segment is expected to have significant growth in the market. The increasing number of brain diseases along with the integration of advanced technology in the diagnostic centers responsible for the segmental growth in the brain mapping instruments. According to the World Health Organization (WHO), the global prevalence of epilepsy and multiple sclerosis was calculated at 50 million and 2.5 million respectively.
Request for a sample of the report browse through – https://univdatos.com/get-a-free-sample-form-php/?product_id=27902
For a better understanding of the market adoption of the Brain Mapping Instrument industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America constitutes a significant brain mapping instruments market due to the increasing R&D activities and frequent product launches in the region. Furthermore, the changing lifestyle in the region is affecting the sleep cycle of the people and leads to the shortening of sleep which ultimately cause different mental and neurological disorders. For instance, as per the Canadian government, 1 in 2 adults have trouble going to sleep or staying asleep and 1 in 5 adults does not find their sleep refreshing.
Some of the major players operating in the market include Medtronic, GENERAL ELECTRIC COMPANY, Koninklijke Philips N.V., Siemens Healthcare Private Limited, Advanced Brain Monitoring Inc., Natus Medical, Inc., Covidien PLC., Nihon Kohden Corporation, Canon Medical Systems Corp., and Cadwell Industries Inc.
Global Brain Mapping Instrument Market Segmentation
Market Insight, by Product Type
Market Insight, by End-users
Market Insight, by Region
Top Company Profiles
Get a call back